Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A PHASE 1/2 STUDY OF RO4929097, AN ORAL SMALL MOLECULE INHIBITOR OF GAMMA-SECRETASE, IN CHILDREN WITH RELAPSED/REFRACTORY SOLID OR CNS TUMORS, LYMPHOMA, OR T-CELL LEUKEMIA

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT01088763
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:35:49.258877+00:00
Published At
2014-11-05T00:00:00+00:00
Record Updated At
2014-11-05
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Childhood Atypical Teratoid/Rhabdoid Tumor", "Childhood Central Nervous System Choriocarcinoma", "Childhood Central Nervous System Germinoma", "Childhood Central Nervous System Mixed Germ Cell Tumor", "Childhood Central Nervous System Teratoma", "Childhood Central Nervous System Yolk Sac Tumor", "Childhood Choroid Plexus Tumor", "Childhood Craniopharyngioma", "Childhood Ependymoblastoma", "Childhood Grade I Meningioma", "Childhood Grade II Meningioma", "Childhood Grade III Meningioma", "Childhood Infratentorial Ependymoma", "Childhood Medulloepithelioma", "Childhood Mixed Glioma", "Childhood Oligodendroglioma", "Childhood Supratentorial Ependymoma", "Gonadotroph Adenoma", "Pituitary Basophilic Adenoma", "Pituitary Chromophobe Adenoma", "Pituitary Eosinophilic Adenoma", "Prolactin Secreting Adenoma", "Recurrent Childhood Acute Lymphoblastic Leukemia", "Recurrent Childhood Anaplastic Large Cell Lymphoma", "Recurrent Childhood Brain Stem Glioma", "Recurrent Childhood Central Nervous System Embryonal Tumor", "Recurrent Childhood Cerebellar Astrocytoma", "Recurrent Childhood Cerebral Astrocytoma", "Recurrent Childhood Ependymoma", "Recurrent Childhood Grade III Lymphomatoid Granulomatosis", "Recurrent Childhood Large Cell Lymphoma", "Recurrent Childhood Lymphoblastic Lymphoma", "Recurrent Childhood Medulloblastoma", "Recurrent Childhood Pineoblastoma", "Recurrent Childhood Small Noncleaved Cell Lymphoma", "Recurrent Childhood Spinal Cord Neoplasm", "Recurrent Childhood Subependymal Giant Cell Astrocytoma", "Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor", "Recurrent Childhood Visual Pathway and Hypothalamic Glioma", "Recurrent Childhood Visual Pathway Glioma", "Recurrent Pituitary Tumor", "Recurrent/Refractory Childhood Hodgkin Lymphoma", "T-cell Childhood Acute Lymphoblastic Leukemia", "T-cell Large Granular Lymphocyte Leukemia", "TSH Secreting Adenoma", "Unspecified Childhood Solid Tumor, Protocol Specific"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2014-11-05"
protocolSection.identificationModule.nctId
"NCT01088763"
protocolSection.identificationModule.officialTitle
"A PHASE 1/2 STUDY OF RO4929097, AN ORAL SMALL MOLECULE INHIBITOR OF GAMMA-SECRETASE, IN CHILDREN WITH RELAPSED/REFRACTORY SOLID OR CNS TUMORS, LYMPHOMA, OR T-CELL LEUKEMIA"
protocolSection.statusModule.overallStatus
"TERMINATED"
protocolSection.designModule.phases
["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Childhood Atypical Teratoid/Rhabdoid Tumor (protocolSection.conditionsModule.conditions)
  • Childhood Central Nervous System Choriocarcinoma (protocolSection.conditionsModule.conditions)
  • Childhood Central Nervous System Germinoma (protocolSection.conditionsModule.conditions)
  • Childhood Central Nervous System Mixed Germ Cell Tumor (protocolSection.conditionsModule.conditions)
  • Childhood Central Nervous System Teratoma (protocolSection.conditionsModule.conditions)
  • Childhood Central Nervous System Yolk Sac Tumor (protocolSection.conditionsModule.conditions)
  • Childhood Choroid Plexus Tumor (protocolSection.conditionsModule.conditions)
  • Childhood Craniopharyngioma (protocolSection.conditionsModule.conditions)
  • Childhood Ependymoblastoma (protocolSection.conditionsModule.conditions)
  • Childhood Grade I Meningioma (protocolSection.conditionsModule.conditions)
  • Childhood Grade II Meningioma (protocolSection.conditionsModule.conditions)
  • Childhood Grade III Meningioma (protocolSection.conditionsModule.conditions)
  • Childhood Infratentorial Ependymoma (protocolSection.conditionsModule.conditions)
  • Childhood Medulloepithelioma (protocolSection.conditionsModule.conditions)
  • Childhood Mixed Glioma (protocolSection.conditionsModule.conditions)
  • Childhood Oligodendroglioma (protocolSection.conditionsModule.conditions)
  • Childhood Supratentorial Ependymoma (protocolSection.conditionsModule.conditions)
  • Gonadotroph Adenoma (protocolSection.conditionsModule.conditions)
  • Pituitary Basophilic Adenoma (protocolSection.conditionsModule.conditions)
  • Pituitary Chromophobe Adenoma (protocolSection.conditionsModule.conditions)
  • Pituitary Eosinophilic Adenoma (protocolSection.conditionsModule.conditions)
  • Prolactin Secreting Adenoma (protocolSection.conditionsModule.conditions)
  • Recurrent Childhood Acute Lymphoblastic Leukemia (protocolSection.conditionsModule.conditions)
  • Recurrent Childhood Anaplastic Large Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Recurrent Childhood Brain Stem Glioma (protocolSection.conditionsModule.conditions)
  • Recurrent Childhood Central Nervous System Embryonal Tumor (protocolSection.conditionsModule.conditions)
  • Recurrent Childhood Cerebellar Astrocytoma (protocolSection.conditionsModule.conditions)
  • Recurrent Childhood Cerebral Astrocytoma (protocolSection.conditionsModule.conditions)
  • Recurrent Childhood Ependymoma (protocolSection.conditionsModule.conditions)
  • Recurrent Childhood Grade III Lymphomatoid Granulomatosis (protocolSection.conditionsModule.conditions)
  • Recurrent Childhood Large Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Recurrent Childhood Lymphoblastic Lymphoma (protocolSection.conditionsModule.conditions)
  • Recurrent Childhood Medulloblastoma (protocolSection.conditionsModule.conditions)
  • Recurrent Childhood Pineoblastoma (protocolSection.conditionsModule.conditions)
  • Recurrent Childhood Small Noncleaved Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Recurrent Childhood Spinal Cord Neoplasm (protocolSection.conditionsModule.conditions)
  • Recurrent Childhood Subependymal Giant Cell Astrocytoma (protocolSection.conditionsModule.conditions)
  • Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor (protocolSection.conditionsModule.conditions)
  • Recurrent Childhood Visual Pathway and Hypothalamic Glioma (protocolSection.conditionsModule.conditions)
  • Recurrent Childhood Visual Pathway Glioma (protocolSection.conditionsModule.conditions)
  • Recurrent Pituitary Tumor (protocolSection.conditionsModule.conditions)
  • Recurrent/Refractory Childhood Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
  • T-cell Childhood Acute Lymphoblastic Leukemia (protocolSection.conditionsModule.conditions)
  • T-cell Large Granular Lymphocyte Leukemia (protocolSection.conditionsModule.conditions)
  • TSH Secreting Adenoma (protocolSection.conditionsModule.conditions)
  • Unspecified Childhood Solid Tumor, Protocol Specific (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.